The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 24, 2017
Filed:
Feb. 18, 2016
Applicant:
Tris Pharma, Inc., Monmouth Junction, NJ (US);
Inventors:
Ketan Mehta, Princeton, NJ (US);
Yu-Hsing Tu, West Windsor, NJ (US);
Assignee:
TRIS PHARMA, INC, Monmouth Junctoin, NJ (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/48 (2006.01); A61K 31/137 (2006.01); A61K 31/155 (2006.01); A61K 31/192 (2006.01); A61K 31/216 (2006.01); A61K 31/4458 (2006.01); A61K 31/485 (2006.01); A61K 9/00 (2006.01); A61K 9/50 (2006.01); A61K 9/10 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 45/06 (2006.01); A61K 31/135 (2006.01); A61K 9/14 (2006.01); A61K 31/4402 (2006.01); A61K 47/32 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48184 (2013.01); A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 9/10 (2013.01); A61K 9/14 (2013.01); A61K 9/167 (2013.01); A61K 9/1664 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2031 (2013.01); A61K 9/2077 (2013.01); A61K 9/2081 (2013.01); A61K 9/5021 (2013.01); A61K 9/5026 (2013.01); A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/155 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/4402 (2013.01); A61K 31/4458 (2013.01); A61K 31/485 (2013.01); A61K 45/06 (2013.01); A61K 47/32 (2013.01); A61K 47/489 (2013.01); A61K 47/48169 (2013.01); A61K 47/48853 (2013.01); A61K 47/48876 (2013.01);
Abstract
A particulate, barrier coated drug-anion exchange resin complex comprising a core composed of an acidic drug complexed with a pharmaceutically acceptable ion-exchange resin is provided. The barrier coating contains a polyvinyl acetate polymer and a plasticizer. Methods of making and products containing this coated complex are described.